Document is current
Any future updates will be listed below
-
Authors
Lahiri, Keya Rani
Singh, Raghvendra
Apte, Mohini
Patil, Mahantesh
Taksande, Amar
Varona, Rafael
Chatterjee, Godhuli
Verma, Manish
Brette, Sandrine
Perez, Marcos III
-
Funding
Funding for this research was provided by:
Sanofi (NA)
- License Information
-
More Information
Article History
Received: 13 September 2021
Accepted: 13 January 2022
First Online: 10 April 2022
Declarations
:
: Ethical approval was obtained from the Independent Ethics Committee for each study site. The study was conducted in accordance with all applicable laws, rules and regulations and with the Declaration of Helsinki and the International Council for Harmonization guidelines for Good Clinical Practice. The parents/legal guardians of all children participating in the study provided their written, informed consent at the time of the child’s enrollment.
: Not applicable.
: KL: Has been the National Coordinator and Principal Investigator (site 5) for the KIDDIE study and has been invited for KIDDIE study related expert meetings. RS: Investigator fees were paid to the Institution on behalf of the Investigator as per the CTA. Holds shares in Sanofi India. MA: Investigator of the KIDDIE study. MP: Investigator of the KIDDIE study. AT: Investigator of the KIDDIE study. RV: Sanofi employee. GC: Sanofi employee. MV: Former Sanofi employee. SB: Employed by Aixial, contracted by Sanofi. MP: Sanofi employee.
